As of Apr 20
| +0.24 / +1.22%|
The 8 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 50.00, with a high estimate of 61.00 and a low estimate of 40.00. The median estimate represents a +151.26% increase from the last price of 19.90.
The current consensus among 8 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.